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ABSTRACT 
 
 Endocannabinoids, and the fatty acid amides from which they are a member, 
have garnered greater scientific interest in the last two decades due to their 
cannabimimetic properties. The most well-known of these is anandamide, which has 
thus far been discovered in several species of animal ranging from C. elegans, fruit 
flies, to bovine and humans. Because of the importance and increasing impact of 
these compounds a brief overview is presented herein, with a major focus on the N-
acyldopamines due to the direct impact they potentially pose to human physiology.  
Secondly, the detection and quantitative analysis of these molecules was 
conducted in the recently fully genome sequenced honeybee and red flour beetle, 
due in part to recent research showing the existence of these molecules in D. 
melanogaster, to which no known cannabinoid receptors had been found to date. 
Interest in these potentially new model organisms may provide additional insight 
not only into the endocannabinoids but also as potential targets for protection of 
honeybees and pest control of red flour beetles.  
Utilizing established HPLC-MS methods for the detection and quantification of 
these compounds provided a series of endogenous results for these molecules 
within both farmed and feral honeybees and the red flour beetle. Additionally, a 
protein sequence and motif homology study with a newly discovered 
acyltransferase from Fruit flies shows strong evidence that a similar enzyme is 
expressed in both honeybees and red flour beetles. Therefore providing future steps 
for the continuation of this research to better elucidate and quantify the 
endocannabinoids as well as determine the biosynthetic metabolism within these 
organisms. 
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CHAPTER 1:  
 
INTRODUCTION, BACKGROUND AND CURRENT REVIEW OF 
ENDOCANNABINOIDS/FATTY ACID AMIDES 
 
 
1.1  Introduction to Endocannabinoids (eCBs) and Fatty Acid Amides (FAAs) 
 
The detection of biological fatty acid amides, and their metabolites, dates 
back to the initial discovery in horse urine by Justus von Liebig in 1829. (1) The 
biological role of these bioactive lipids are still of importance within the biochemical 
and medical fields and have been related to physiological conditions ranging from 
diabetes and renal function to autism and infections. (2) Long-chain fatty acid 
amides (FAAs), in which the long-chain primary fatty acid acyl group is the defining 
characteristic, were first extracted and characterized starting in 1957. (3) Several 
classes of FAAs are now currently known, including derivatives of important 
biologically and neurologically-active compounds such as N-acylethanolamines and 
N-acyldopamines (Table 1.1). (4)  
Endocannabinoids (eCBs) are defined as endogenous cannabimimetic FAA-
derived molecules that illicit physiological effects similar to those of the active 
molecules present in marijuana and similar cannabis plants, Δ9- 
tetrahydrocannabinol and cannabidiol, from which the term is derived. (5) 
Additionally, endocannabinoids are structurally characterized as lipid mediators with 
either long-chain saturated, unsaturated or polyunsaturated fatty acid moieties. 
Like the related FAAs, eCBs can be classified as amide, ester or ether derivatives. 
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The detection of N-arachidonylethanolamine in 1992 in the porcine brain marked 
the initial discovery of a fatty acid amide compound shown to produce 
endocannabic effects (commonly known as anandamide, from the ancient Sanskrit 
word for “bliss”). (6) Anandamide (AEA) is thus considered the prototypical 
endocannabinoid. 
Over the last two decades several additional endogenous eCB/FAA 
derivatives have been discovered in organisms ranging from C. elegans (7), fruit 
flies (8), reptiles (9) bovine (10), sheep (11), mice (10), rats (12, 13) and humans 
(14, 15) to even fungi (16). Additionally, there is evidence to suggest that eCBs are 
also present in chocolate. (17) A select group of relevant eCB/FAA derivatives and 
known N-acyl moieties are presented in Table 1.2. 
Ongoing research into the endogenous biosynthesis and function of these 
molecules continues to show their primary location in brain or central nervous 
system tissue, such as the substantia nigra (15), specific neuronal cells (10), 
cerebrospinal fluid (17), choroid plexus (10) and blood serum (19). The early 
research into the function, potential receptor and bioactivity of anandamide used 
extracted rat synaptic tissue (6) and live mice (18). It was the initial study by 
Devane that suggested the potential receptor for AEA as being cannabinoids in vivo. 
(6)  
The primary receptors which have been extensively studied with eCBs as 
potential ligands include mammalian cannabinoid receptors, CB1/CB2, and the 
transient receptor potential vanilloid type 1 channel, TRPV1. (5) Other research has 
shown that eCBs may also act as ligands to receptor proteins such as G-protein-
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coupled receptor 119 (GPR119) and peroxisome proliferator-activated receptor 
gamma and alpha (PPARγ/PPARα). (19, 20) 
Though the exact function of these receptors is not completely known 
numerous studies suggest several notable physiological effects including the 
modulation of pain perception, sleep induction, body temperature, locomotion, 
appetite and even fear and anxiety (Table 1.2). (21) It is primarily due to these 
effects that the eCBs/FAAs are an ever-increasing research area of interest, both as 
potential therapeutic targets and to better understand the physiology involved. 
 
1.2  Anandamide and Other NAEs 
 
 
Figure 1.1: Major NAE Derivatives, incl. anandamide (AEA). 
 
 As stated, anandamide is considered the prototypical endocannabinoid not 
only because it was the first discovered within the eCB metabolome but also due to 
the high research interest it garnered by its physiological roles to date, those roles 
being cannabimimetic in nature, and is only one of several within the N-
acylethanolamine (NAE) family (Fig. 1.1).   
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Table 1.1: Families of endocannabinoids/fatty acid amides, major acyl forms and 
known endogenous organisms. R2 represents the amino acid group. 
eCB/FAA Class Major N-acyl Moieties, R1 
Endogenous 
Organisms 
 
 
 
 
N-Acylethanolamine (NAE) 
 
Palmitoyl (C14:0) 
Oleoyl (C18:1 cis-Δ9) 
Arachidonoyl (C20:4 cis-Δ5,8,11,14) 
C. elegans 
Fruit Fly 
Reptiles 
Rodents 
Cows & Pigs 
Cats & Rabbits 
Human 
 
 
N-Acylamino acid (NAA) 
 
Palmitoyl (C14:0) 
Oleoyl (C18:1 cis-Δ9) 
Arachidonoyl (C20:4 cis-Δ5,8,11,14) 
Fruit Fly 
Rodents 
Cows & Pigs 
Cats & Rabbits 
Human 
 
 
N-Acyldopamine (NAD) 
 
Palmitoyl (C14:0) 
Oleoyl (C18:1 cis-Δ9) 
Arachidonoyl (C20:4 cis-Δ5,8,11,14) 
Fruit Fly 
Rodents 
Cows 
Human 
 
 
 
Primary Fatty Acid Amide 
(PFAA) 
 
Palmitoyl (C14:0) 
Palmitoleoyl (C16:1 cis-Δ9) 
Oleoyl (C18:1 cis-Δ9) 
Linoleoyl (C18:2 cis,cis-Δ9,12) 
Eicosenoyl (C20:1 cis-Δ13) 
Arachidonoyl (C20:4 cis-Δ5,8,11,14) 
C. elegans 
Fruit Fly 
Rodents 
Cows & Pigs 
Cats & Rabbits 
Human 
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Table 1.2:  The major eCB/FAA groups and known receptors with biological effects  
N-Acylethanolamine 
(NAE) 
 
Anandamide 
N-Oleoylethanolamine 
N-Palmitoylethanolamine 
 
CB1/CB2 
TRPV1 
PPARγ/PPARα 
Sleep, Pain, 
Body 
Temperature, 
Appetite & 
Anxiety 
N-Acylamino acid 
(NAA) 
 
N-Arachidonoylglycine 
N-Arachidonoyltaurine 
 
 
CB1/CB2 
TRPV1 
PPARγ/PPARα 
 
Pain, Body 
Temperature & 
Anti-
inflammatory 
N-Acyldopamine 
(NAD) 
 
N-Arachidonoyldopamine 
N-Oleoyldopamine 
N-Palmitoyldopamine 
 
CB1/CB2 
TRPV1 
PPARγ/PPARα 
 
Sleep, Pain & 
Anxiety 
Primary Fatty Acid 
Amide (PFAA) 
 
Eicosenoamide 
Linoleamide 
Oleamide 
Palmitamide 
CB1 
PPAR 
5-HT1A/2A 
 
Sleep, Pain, 
Body 
Temperature, 
Appetite & 
Anxiety 
  
 Fride and Mechoulum, colleagues of Devane, were the first to provide an in 
vivo analysis of the effects of anandamide within a mammalian organism (mice). 
(18) In general, cannabis’ effects on mammals are dose-dependent, and thus range 
from simultaneous depression and stimulation at low doses to more extensive 
central depression at high doses. Using a classic tetrad series of behavioral tests 
with anandamide and Δ8-THC for these cannabic effects it was shown that the two 
compounds produced remarkable similarity in the expected effects from the 
majority of test animals. Examples of these tests included antinociception 
(decreased pain sensation), measured hypothermia and physical activity. (22) Such 
research also concluded that, as cannabic effects occur in the central nervous 
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system, anandamide readily crosses the blood-brain barrier and suggested possible 
cellular transporters specific to these compounds.  
 As a result of the early research into the in vivo effects of anandamide it was 
clear that specific receptors existed for these molecules. Receptors for the active 
psychotropics in Cannabis had already been known, the cannabinoid receptors 1 
and 2 (CB1/CB2); and the results by Fride and Mechoulom lent clear evidence that 
anandamide and other endocannabinoids were endogenous ligands to these 
receptors. (23, 24) What was still unclear at that time was the biological purpose 
and biosynthesis of molecules like anandamide. Interestingly enough anandamide is 
one of the least abundant of the NAEs in the mammalian brain, consisting less than 
10% of the total endogenous amounts to date of NAEs known. Several other NAEs 
were since detected and measured within various organisms since the initial 
discovery by Devane et al., including N-palmitoylethanolamine (PEA), N-
oleoylethanolamine (OEA) and various others ranging from N-stearoylethanolamine 
(SEA) and N-linoleoylethanolamine (LEA) to N-dihomo-γ-linoleoylethanolamine 
(DLEA) and N-docosatetraenoylethanolamine (DEA). (21)  
In addition to the cannabinoid receptors, other receptors were discovered to 
be paired to endocannabinoids such as the transient receptor vanilloid type 1 
(TRPV1), transient receptor potential of melastatin 8 (TRPM8), G-coupled-protein 
receptor 119 and peroxisome proliferator-activated receptors alpha and gamma 
(PPARα,γ). (25, 26, 20,27, and 28) For anandamide the binding constants with 
these receptors vary greatly (Kd = 61 – 11,000 nM), with higher affinity for CB1/CB2 
and lower affinities for PPARγ. (21) A select few NAEs, like SEA, have exhibited 
cannabimimetic effects without binding to any known cannabinoid receptors, thus 
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suggesting the possible existence of a heretofore unknown cannabinoid receptor 
(potentially, “CB3”). (29) 
 Furthermore, much of the research into the various eCB NAEs like AEA, OEA 
and PEA have continued to suggest what has become known as the “entourage 
effect,” in which interactions of these molecules can augment substrate-ligand 
binding. (30) This effect may explain some of the observed competing activities of 
these NAEs for the various receptors, and the large variations in endogenous 
amounts, due to the promiscuity of NAEs for the NAE-degradation enzymes known 
for anandamide; thus resulting in cellular concentration stabilization. (21, 30, and 
31)  
 Despite the extensive research into the biological nature of anandamide and 
the NAEs the biosynthetic and degradation routes for these molecules is complex 
with few clear answers thus far. Several articles have provided sound arguments for 
several biosynthetic routes, with the most widely accepted among them currently 
being the N-acylphosphotidylethanolamine (NAPE) specific phospholipase-D 
dependent (NAPE-PLD) synthesis. The NAPE-PLD route catalyzes the cleavage of 
NAPE into the corresponding NAE and phosphotidic acid. (32) Several additional 
routes related to these and similar enzymes have been proposed as well. A more 
thorough discussion can be accessed from Waluk, et al., 2014 (21).  
 The degradative routes for the NAEs are also equally as complex and varied. 
Current literature strongly suggests the use of fatty acid amide hydrolase (FAAH) 
for the hydrolytic degradation of NAEs to ethanolamine and free fatty acid, while 
other research also suggests an oxidative pathway to the N-acylated amino acid N-
acylglycine via fatty aldehyde dehydrogenase. (33, 34). Several of the metabolites 
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from these pathways have been implicated in additional bioactivity, suggesting 
alternative routes of regulation. (35, 36, and 37) Indeed, research has progressed 
with FAAH inhibition as a potential therapeutic route for the treatment of various 
neuropathological states such as Alzheimer’s and Parkinson’s diseases. (38) 
 Recent research into the physiological roles of the NAEs has added to an 
ever-increasing list beyond those previously mentioned. Some of these roles include 
human reproduction and fertility (39, 40). Continued research also includes the use 
of NAEs as anxiolytics and antidepressant therapeutics (41, 42).  
 
1.3  N-Acyldopamines:  Physiological Role, Biosynthesis and Degradation 
 
Because of the substantial physiological role that dopamine occupies in 
vertebrate species the N-acyldopamine-derived endocannabinoids are especially of 
interest in the scope of this review. 
 
Figure 1.2: The Four Major N-Acyldopamine eCB Derivatives. 
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1.3.a.  Physiological Role 
 
As first reported by Huang, et al. in 2002, a small number of N-
acyldopamines, such as N-arachidonoyldopamine (NADA), have been identified in 
mammalian brain tissues, with the highest concentrations within the hippocampus, 
striatum and cerabellum. (43) Additionally, NADA was shown to be a potent agonist 
(EC50 ≈ 50 nM) of the nonselective cation channel TRPV1 in both human and rats 
with similar efficacy to that of capsaicin, a non-endogenous mediator of TRPV1. The 
Huang group described the ability of NADA to induce TRPV1-mediated hyperalgesia 
in rats intradermally (EC50 = 1.5±0.3 μg). Before direct studies of NADs with TRPV1 
were conducted, previous research indicated their role in pain mediation as a 
molecular transducer of chemical and physical nociceptive stimulus. (44) Shortly 
before the endogenous detection of NADs, NADA was found to be a greater CB1 
agonist than anandamide, producing: hypothermia, hypo-locomotion, catalepsy, 
and analgesia. It was also found, along with N-pinolenoyldopamine and N-
docosapentaenoyldopamine, to inhibit FAAH activity. (45) 
Chu and colleagues of the Huang group had shown the existence of 
endogenous levels of additional long-chain N-acyldopamines: N-stearoyldopamine 
(STEARDA), N-palmitoyldopamine (PALDA) and N-oleoyldopamine (NOLDA). (46) In 
this study, it was shown that the saturated fatty acyl derivatives STEARDA and 
PALDA had no effect on calcium influx or thermal hyperalgesia via the TRPV1 
receptor. However, NOLDA, an unsaturated derivative, caused calcium influx and 
thermal hyperalgesia via TRPV1 with similar potency to that of NADA (EC50 ≈ 36 nM 
and ≈ 17 nM, respectively). Unlike NADA, NOLDA was shown to be a weak ligand 
10 
 
for CB1. Like NADA, NOLDA was shown to be a ligand for the anandamide 
membrane transporter but a poor substrate for FAAH (therefore suggesting an 
additional route of degradation). The dichotomy between the saturated and 
unsaturated fatty acyl derivatives of N-acyldopamine suggests the requirement of 
an unsaturated acyl chain for optimal binding and function with TRPV receptors. The 
key seminal research by Huang, Chu and colleagues had shown that endogenous N-
acyldopamines are putative substrates to TRPV1 receptors and opened the door to 
research in the field of these molecules and their neurological function. 
It has also been noted that TRPV1 is the only one in the family of TRPV 
receptors that is activated by both endogenous long-chain acyl derivatives and 
capsaicin. (47) PALDA and STEARDA were studied as enhancers of the binding of 
other NADs to the TRPV1 receptor. It was found that the EC50 of NADA on the 
TRPV1 receptor was significantly lowered in the presence of PALDA and STEARDA 
(from 90 nM to 30 nM). This enhancement was also found to be true for 
anandamide on Ca2+ levels in the studied HEK-293 cells overexpressing human 
TRPV1. At low pH, it was discovered that PALDA and STEARDA could significantly 
increase Ca2+ levels in the cells. Hyperalgesia was then tested in the rat hind paw 
using a radiant heat source. It was determined that the observed sensitivity to heat 
was much higher in the rat hind paws treated with both N-arachidonoyldopamine 
and STEARDA than either of the two molecules alone. STEARDA and PALDA had 
thus been shown to modulate the activity of TRPV1 under specific conditions, 
leading to a sensitization of the receptor with respect to these ligands. Thus, it was 
suggested that there is an entourage effect in the mechanism of action of the N-
11 
 
acyldopamines with TRPV1, which has also been seen with anandamide and the N-
acyldopamines upon TRPV1. (30) 
Early research by Pokorski, et al. showed the ability of NOLDA to cross the 
blood brain barrier, thus suggesting its use as a transporter of dopamine into the 
brain. (48) 
Focus on the hyperalgesic/analgesic functions of NADs continued with the 
TRPV and CB receptors. Bianchi, et al. examined whether NADA, NOLDA, and AEA 
affected TRPV1 receptors in HEK293 and 1321N1 brain astrocyte cells by measuring 
the levels of calcium influx. (49) NOLDA was shown to have a reduced effect 
compared to NADA and AEA in HEK293 cells and markedly so in 1321N1 cells, while 
decreases in pH increased this difference. Additional research indicates that NOLDA 
could exert cardiac protective effects mediated by TRPV1 in wild-type mice when 
compared to TRPV1-null mutant mice. (50) The anti-nociceptive potential of NADA, 
based on hyperalgesia research, was further established by studying the interaction 
of NADA and endomorphin-1 in rats at the spinal level. (51) NADA was shown to 
have dose-dependent anti-hyperalgesia effects but was 5.4 times less potent than 
endomorphin-1. Additionally, both TRPV1 and CB1 antagonists/inverse agonists 
reduced these effects at higher concentrations. 
Continued research with NADs has now provided evidence that these 
molecules are potential mediators of neurological function. (52) NADA’s action upon 
dopaminergic neurons has been shown to be mediated by glutaminergic/GABAergic 
transmission via TRPV1/CB1 receptors, thus suggesting a role for NADs in synaptic 
transmission regulation. This study hypothesized that the activation of either TRPV1 
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or CB1 by NADA was caused by increases in glutaminergic and GABAergic 
transmission respectively. NADA may also show inhibitory aspects upon 
dopaminergic neurons with glutaminergic transmission via the CB1 receptor. Further 
work by Ferreira et al. in 2009, had shown that NADA, NOLDA, and PALDA were 
found to cause the uptake of calcium and the release of dopamine and glutamate in 
striatal nerve terminals, possibly by ligand-gated ion channels, which continued to 
occur in TRPV1-null mutant mice. (53) TRPV1 antagonists and the absence of 
potassium indicated no change in this effect, while Gd3+ inhibited the effect with 
high potency in low nanomolar ranges. 
Earlier work with N-acetyldopamine has shown it to be an inhibitor of 
sepiapterin reductase, an intermediate enzyme in the biosynthesis of 
tetrahydrobiopterin (an enzyme cofactor for the biosynthesis of various 
neurotransmitters). (54) Recent research by Grabiec and colleagues has indicted 
that NADA exerts neuro-protective effects via CB1 receptors, but not with TRPV, 
after excitotoxic damage. (55) These effects were blocked by the AM251 CB1 
receptor antagonist and absent in CB1-null mutant mice. This work hypothesized 
the role of NADs as novel drug targets to mitigate neuronal damage. 
Recent research on T-type calcium channels with NADs has indicated their 
potential as anti-epileptics. (56) NADA was shown to potently inhibit recombinant 
human T-type calcium channels (EC50 = 300nM-1µM). NOLDA gave similar results 
while PALDA had miniscule results. For a more rigorous review of N-acyl amino 
acids and neurotransmitters on these various other receptors, the reader is 
encouraged to refer to Conner, et al. 2010. (56) 
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Explorations in NAD research have indicated their potential role as 
neurobiological anti-inflammatory leads. (57, 58) NADs have been shown to induce 
increases in COX-2 expression within brain endothelial cells via regulation of PGE2 
and PGD2, thereby mediating prostaglandin production. (59) Furthermore, Dang 
and others reported that NADs and analogues are potent anti-inflammatory leads 
against pro-inflammatory mediators/cytokines such as TNF-α. (60, 61) Additionally, 
it is noted that NADA and other endocannabinoids stimulate the transcription 
activity of PPARγ, a key enzyme in fatty acid metabolism. (58) As endocannabinoids 
are known to be part of the eicosanoid biosynthetic pathway the action of NADs on 
these systems may potentially be negative feedback regulation pathways. 
Additional research with NADs outside of their traditional hyperalgesia effects 
has led to recent research into their potential role as thermogenic (anti-obesity) 
drugs. Research conducted by Mahmmoud and colleagues has shown NADA to be 
an uncoupling agent of sarcoplasmic reticulum Ca2+-ATPase (SERCA). (62) Earlier 
work by Sharkey and colleagues had indicted NAD’s roles as anti-emetics with 
CB1/TRPV1 receptors in ferrets. (63) The results showed that NADA reduced the 
effects of emesis and was similarly inhibited by the antagonist AM251 at 10 mg/kg. 
Their research further indicated that endocannabinoids like NADs preferentially 
inhibit emesis in the brain stem via CB1 when compared to TRPV1.  
Non-cannabinoid and “orphaned” G-protein coupled receptors have also been 
proposed as potential targets of NADs (in particular GPR55 and GRP119) and have 
shown similar effects with other endocannabinoid receptors and their corresponding 
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effects, such as inflammation mediation. Additionally, NADA has been shown to 
have activity with TRPM8, a receptor similar in function to TRPV1.  
 
1.3.b.  Biosynthesis and Degradation 
A primary question of NADs as eCBs in the mammalian system is the discrete 
biosynthetic and degradation processes in vivo and is considered a primary goal of 
NAD-eCB research. 
For the biosynthesis of NADs the primary question is how and where the NAD 
precursors acquire the acyl group. Huang and colleagues initially proposed the 
biosynthesis of NADs from the formation of acyl-CoAs via acyl-coA synthetase and 
their subsequent conjugation with dopamine via an acyl transferase (see Figure 
1.3, Pathway IIb,c). (10, 43) Degradation by FAAH was proposed, for which known 
metabolites exist (Fig. 1.5). Additional research by Huang and colleagues gained 
further evidence for these hypotheses as well as a possible biosynthetic route from 
N-acyltyrosines (NATyro) using the pre-existing dopamine biosynthetic enzymes of 
tyrosine decarboxylase (TDC), tyrosine hydroxylase (TH) and DOPA decarboxylase 
(DDC) (Fig. 1.3 and 1.4). Evidence was also shown for an alternative degradation 
pathway via methylation of NADs by catechol-O-methyltransferase (COMT) (Fig. 
1.5). However, degradation by COMT was slow, suggesting metabolism by 
methylation as a partial or secondary route.  In the Huang study, it was further 
shown that radiolabeled arachidonic acid with dopamine or tyrosine both produced 
radiolabeled NADA, including evidence of the formation of a radiolabeled NADA-like 
molecule from tyrosine with the inhibition of tyrosine hydroxylase. Such research 
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suggests that both of the proposed pathway sets shown herein are possible (Figs. 
1.3 and 1.4). 
Recently, Hu and colleagues further reported on these two possible 
biosynthetic pathways for the NADs. (64) In their study it was proposed that NAD 
biosynthesis required TH in the dopaminergic terminals, thus further suggesting the 
presence of a putative NATyro or N-acyltyramine (NATyra) derivative. Though an 
NATyro derivative was found within rat brains it was determined not to be an 
intermediate in NAD biosynthesis. This conclusion was due to inhibiting TH, which 
showed no increase in NATyro but a subsequent decrease in NAD levels (27% of 
control). Additionally, this study showed that radiolabeled NATyro gave very low 
conversion to N-acyl-L-DOPA (NADOPA) with TH incubation, compared to the 
natural molecules, indicating that NATyro is a poor substrate for TH. Incidentally, 
radiolabeled NADOPA was shown not to be a direct precursor of NAD in vivo, 
thereby implying the possibility that N-acylation does not occur in conjunction with 
NATyro-dependent DOPA decarboxylase. Furthermore, mammalian brain 
incubations with dopamine and arachidonoyl-coA/arachidonic acid phospholipid 
esters gave no detectable levels of the expected NAD, thus suggesting that 
acylation occurs prior to the final conversion to dopamine. As a result of this data it 
was concluded that NAD biosynthesis likely does not occur via the acylation and 
metabolism of NATyro or NADOPA in conjunction with either TH or DDC (Fig 1.4, 
Tyrosine-dependent Pathway Ib) nor is the acyl-coA-mediated acylation of 
dopamine likely as well (Fig. 1.3, Pathways IIa and IIb). Additional studies by 
Bezuglov and colleagues upheld this hypothesis by showing that the biosynthesis of 
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NATyro was not detected in rat liver and nerve tissues, while NADs and N-
acylphenylalanine were detected. (65) 
Hu, et al., further studied the second proposed biosynthetic pathway 
involving the direct condensation of a free fatty acid with dopamine (Fig 1.3, 
Pathway IIc). (64) Their study was conducted via rat brain incubations with 
radiolabeled arachidonic acid or radiolabeled dopamine. The expected radiolabeled 
NADA was detected, with no indication of NADA in buffer or boiled membranes 
(control). Based on those results, FAAH-inhibited rats and FAAH-knockout mice 
were examined with controls to show marked increases in AEA and decreases in 
NADA for both animals, supporting a possible FAAH-mediated NAD biosynthetic 
pathway. Additionally, it was reported that NADA was a poor substrate for 
recombinant FAAH while AEA gave high levels of hydrolysis to the free fatty acid. 
However, small amounts of NADA production were detected with 
AEA/dopamine/FAAH incubations despite steps taken to eliminate possible mass 
spectrometry carry-over. It was thus concluded that the biosynthesis of NADs likely 
involves an enzyme-mediated condensation of a free fatty acid with dopamine 
rather than an acyl-coA. FAAH may be a possible conjugation enzyme and/or a 
rate-limiting enzyme for the release of free fatty acid from the corresponding 
primary fatty acid amide. It was noted, however, that FAAH is an integral 
membrane protein and that recombinant FAAH is unbound in vitro, likely affecting 
its chemistry. Earlier research could suggest the possibility of a negative feedback 
route between FAAH and NADA, if FAAH is indeed involved in the biosynthesis of 
NADs. (45) 
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Recent research into the degradation of NADs has lent increased evidence 
towards methylation by COMT, which has been found to be an inactivator of NADA 
after interaction with the TRPV1 receptor (Fig. 1.5). (66, 67)  
Akimov and colleagues proposed the oxidation of NADs via pmNOX, and 
more recently have shown the sulfation of NADs via aryl sulfotransferases (AST). 
(68, 69) It was determined that NADs (arachidonoyl-, oleoyl- and cervonoyl-) were 
sulfated via AST in rat liver, spinal cord and brain homogenates with relatively 
robust activities compared to COMT- and FAAH-mediated degradation pathways 
previously proposed. 
Concurrently, work by Rimmerman et. al. indicate that NADA is metabolized 
by Cytochrome P450 to the observed omega/omega-1 hydroxylated NAD 
metabolites. (70) These metabolites were suggested to have a wider range of 
effects with lower potency. 
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Figure 1.3: Proposed L-DOPA/Dopamine-Dependent NAD Biosynthetic Pathways. 
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1.4 Conclusions 
 
 Endocannabinoid/fatty acid amide research is an ever-evolving and complex 
field of research within biochemistry and molecular biology. Other families of these 
molecules, such as the N-acylamino acids and primary fatty acid amides, have 
yielded research similar to those discussed herein but a thorough review is not 
within the scope of this literature. However, one key report by Dempsey, et al., 
recently produced compelling work on the biosynthesis of long-chain N-
acylarylalkylamines (of which N-acyldopamines are a member) using an 
endogenous recombinant N-acyltransferase from Fruit flies. (71) Dempsey and 
colleagues’ work shows the likelihood that (a) an acyltransferase is indeed a major 
part of the biosynthesis for these molecules and (b) previously unknown fatty acid 
derivatives are still being discovered, such as the N-acylserotonin described.  
Continued work such as this emphasizes the complexity of the 
endocannabinoid metabolome and implies the richness of this area for further 
therapeutic research. The possibilities that these various endocannabinoids may 
help treat illnesses such as Alzheimer’s, Parkinson’s, pain, anxiety, depression and 
even appetite implies a whole new realm of potential pharmaceuticals. 
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CHAPTER 2: 
THE DETECTION AND QUANTIFICATION OF ENDOGENOUS 
ENDOCANNABINOIDS/FATTY ACID AMIDES IN A. MELLIFERA 
(HONEYBEES) AND T. CASTANEUM (RED FLOUR BEETLES) 
 
2.1 Introduction and Background 
 The common honeybee (Apis mellifera, Lat. “honey-bearing bee”) and the 
red flour beetle (T. castaneum) are widely considered the most beneficial and most 
destructive cosmopolitan pests in the modern world, respectively. The honeybee is 
the primary commercial pollinator in modern agriculture, as well as producing 
agricultural products like honey and bee’s wax. (1, 2) The red flour beetle, on the 
other hand, consumes up to a quarter of grain crops in the western world alone and 
is considered one of the most destructive pests in agriculture. (3, 4, 5) 
 As a result, extensive research has occurred over many years with regards 
to the roles of these two diametrically opposed insects in the modern world. 
Starting in the 1990’s the phenomenon known as “sudden colony collapse” began a 
pattern of wide-spread loss of commercialized honeybees and crops, resulting in 
low supplies and increasingly high costs for honey and those crops requiring 
pollination. (6, 7)  Grain crop losses from the red flour beetle, and its close relative 
the Confused Beetle (Tribolium confusum) have been estimated as high as 50% of 
total global seasonal yield. (8) 
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For honeybees, the impact of the extensive loss of colonies worldwide is an 
agricultural and commercial issue that cannot be adequately stressed within our 
society. In the event of global catastrophic colony losses for this species a 
cascading effect would result, causing not only massive agricultural and economic 
devastation but also potentially worldwide famine. Such effects could result in the 
deaths of millions. The current theory for the cause of sudden colony collapse is the 
extensive use of pesticides, which likely causes massive die-back within colonies 
including the queen. (2, 6) The mechanism for die-back events from pesticide 
usage is still unclear and hotly debated. Current speculation suggests that 
pesticides may be inhibiting or degrading the honeybee’s individual sensory 
perception and/or the chemical signaling process between colony-mates via the 
specie’s use of communal pheromonal communication.  
In the context of the red flour beetle, conventional pesticides are inadequate 
in controlling the species and any compounds that do are highly toxic upon 
consumption of the treated crops. (9, 10, 11) Increases in pesticide usage have 
several severe environmental and health effects, while showing little results in 
controlling this pest species. A major concern is that as population density 
increases and global temperatures further rise controlling the species will become 
much more difficult and could result in even higher crop losses, especially in 
economically and technologically depressed regions. As a result, much like 
honeybees, wide-spread famine could ensue causing the deaths of millions and 
creating a devastating cascade effect worldwide in terms of economics, agriculture 
and possibly even lead to political strife. 
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 Red flour beetle’s increasing resistance to pesticides is likely due to uneven 
distribution, concentration and exposure. (9, 11, 10) Therefore, it is clear that both 
safer and more effective forms of control are needed to combat red flour beetles 
while limiting the potential hazards of pesticide use against honeybees. Because of 
the importance in pheromone signaling in communal organisms like honeybees, and 
the recent discovery of endocannabinoids and TRP ion channels tied to sensory 
perception present within fruit flies, further research into the role of 
endocannabinoids may prove highly relevant. (12, 13) 
Honeybees present a unique constraint for research however, due in part to 
the inability to completely contain and control them in a laboratory environment, as 
honeybees require the constant ability to forage in the environment or the colony 
would perish. (14) As such, several unknown factors that cannot be easily 
documented and quantified can readily affect the organism and corresponding 
results. While their food supply can be supplemented, it cannot be completely 
controlled; therefore traditional feeding studies are not feasible. The lifecycle and 
life stages of honeybees are also difficult to control and monitor within the certainty 
accustomed to model organisms. Red flour beetles, however, are easily cultured, 
controlled and manipulated in a laboratory setting and have proven to be an 
excellent model organism. (15) 
 In 2001, however, McPartland and colleagues suggested that 
endocannabinoids do not exist in insects. (16) In contrast however recent work by 
Jeffries, et al., have shown otherwise. (12, 17)  The need for additional model 
organisms for continued studies in endocannabinoids were made even more 
relevant in insects due to the full genome sequencing of both honeybees in 2006 
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(18) and in red flour beetles in 2009. (3) As such genomic studies for the 
endocannabic receptors and posited biosynthetic enzymes have shown significant 
sequence homology within these insects between higher order animal species. (17) 
 Some of these key genomic similarities in the context of endocannabinoid 
metabolism include the existence of an arylalkylamine N-acyltransferase (AANAT) 
enzyme recently characterized from fruit flies showing significant homology with 
similar enzymes in both honeybees and red flour beetles (Fig 2.1). (17) 
Due in part to the research recently conducted in Fruit flies on the 
biosynthetic enzyme AANAT, and the sequence homology described herein, the 
usage of honeybees and red flour beetles to further elucidate the role, biosynthesis 
and degradation of endocannabinoids/fatty acid amides is clear.  
Prior to any possible studies involving the AANAT-like enzymes present within 
these organisms it is first necessary to determine the endogenous identities and 
concentrations of the endocannabinoids/fatty acid amides present. Several 
procedures to accomplish this have been developed over the years by various 
groups, in organisms ranging from C. elegans, rats and mice, to cultured cells and 
human tissue. (19, 20, 21) Much of these methods are only feasible with the use of 
separation and spectroscopic techniques such as GC/LC/MS. These techniques are 
not with limitations however, especially with lipid molecules such as the eCBs/FAAs, 
and include oxidation, over-fragmentation, matrix effects and column 
contamination, to name a few. (22, 23, 24) 
Key limitations to note include inherent error with a shared mass 
spectroscopy instrument and chromatography column such as cross-contamination, 
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column degradation and contamination by known labware slip additives Oleamide 
and Palmitamide (25, 26). A significant limitation of note is the oxidation of N-
acyldopamines into the N-acyldopamine quinone/indole specie’s and has greatly 
contributed to the elusiveness of detecting these specific molecules endogenously. 
These reactions are widely documented and difficult to mitigate. Reasons for this 
difficulty are due to sample treatment and exposure to oxidative environments, 
such as air and light, that cause precipitation into di- and tri-polymers similar to 
melanin which are resistant to mass spectroscopy techniques (Figure 2.2). For 
additional information please refer to the review by D’Ischia, et al. (22, 27)  
Despite these limitations herein is presented research into the detection and 
quantification of a set of endocannabinoids/fatty acid amides (Table 2.1) from A. 
mellifera and T. castaneum via high performance liquid chromatography quadropole 
time of flight mass spectroscopy techniques (HPLC/QTOF-MS) along with genetic 
comparisons of the Fruit Fly arylalkylamine N-acyltransferase (AANAT) between 
these organisms.  
Also presented herein is a proposed biosynthetic route to the eCBs/fatty acid 
amides in light of the results shown and suggestions for further research. Overall, 
this research provides additional evidence that endocannabinoids and fatty acid 
amides are endogenous to these two organisms, despite the known cannabinoid 
receptors showing no known expression in insects. In conjunction with the recent 
data from Fruit flies (12) such mounting results demand additional questions as to 
the nature of these compounds and the possibility of heretofore unknown 
cannabinoid-like receptors.   
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Figure 2.2: Select routes of N-acyldopamine oxidation to quinone/indole 
intermediates and final di- and tri-mer products. R represents the long-chain fatty 
acyl moiety. Based on chemistry as described by D’Ischia (22) 
 
 
2.2  Experimental Methods and Procedures 
 All materials and chemicals used herein were acquired from Sigma-Aldrich, 
Co. or Fisher Scientific unless otherwise noted. All fatty acid amide standards were 
purchased from Caymen Chemical, Co.  
 
2.2.a.   A. mellifera (honeybee) Acquisition and Processing 
Honeybees were donated by the USF Botanical Gardens in cooperation with 
Dr. Brent Weisman (USF Department of Anthropology). Two separate batches of 
honeybees were acquired from the botanical gardens. The first batch, labeled as 
“Farmed”, was obtained in late Fall 2013 and comprised approximately of 500 adult 
40 
 
female worker bees (50 grams total mass). The second batch, labeled “Feral”, was 
acquired by Dr. Weisman from a local rogue colony approximately 15-20 miles from 
USF-Tampa campus. The feral bees comprised of approximately 200 adult female 
workers (20 grams total weight). 
Table 2.1: Select endocannabinoids/fatty acid amides to be identified and quantified 
in A. mellifera and T. castaneum within this study 
 
 
Upon immediate acquisition of both batches all samples were placed on dry 
ice for transport to the lab facility for processing. Processing of these samples 
included full immobilization of the organisms in dry ice for 5-10 minutes, 
Compound Abbreviation Molecular Formula
N- Oleoylethanolamine OEA C20H39NO2
N- Arachidonoylethanolamine AEA C22H37NO2
N-Palmitoyldopamine NPD C24H41NO3
N-Palmitoyldopamine Quinone NPDq C 24H 39NO 4
N- Oleoyldopamine NOD C26H43NO3
N-Oleoyldopamine Quinone NODq C 26H 41NO 4
N- Arachidonoyldopamine NAD C28H41NO3
N-Arachidonoyldopamine Quinone NADq C 28H 39NO 4
N-Oleoylserotonin NOS C28H44N2O2
N-Oleoylserotonin Oxid Prod NOSq C 28H 44N 2O 3
N -Palmitoylglycine NPG C18H35NO3
N-Oleoylglycine NOG C20H37NO3
N-Arachidonoylglycine NAG C22H35NO3
Linoleamide LOA C18H33NO
Palmitoleamide POA C16H33NO
Palmitamide PA C16H31NO
Oleamide OA C18H35NO
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transferred to deep freeze containers and weighed then flash frozen over liquid 
nitrogen for 10-15 minutes. After samples were thoroughly frozen the containers 
were tightly sealed and shaken vigorously for 5 minutes to break apart the 
organisms into three separate body parts: head, thorax and abdomen. Incidentally, 
this process also removed the legs, wings and antennae of the organism as well as 
any loose pollen or other particulate matter, wherein this material would collect on 
the wall of the container or settle to the bottom allowing easy separation from the 
organism segments.  These segments were then separated out, while on ice, into 
individual deep freeze vials and weighed. Each vial of segments were then purged 
with nitrogen for 5 minutes, sealed and labeled and then stored at -80° C until 
needed.  
 
2.2.b.   T. castaneum (red flour beetle) Acquisition and Processing 
 Two samples of red flour beetle GA-1 strain were donated by Dr. Susan 
Brown of the Kansas State University Tribolium Genetics Program in early spring of 
2014. These samples were taken from the existing colony where the full genome 
was previously sequenced. The samples were shipped overnight in sealed plastic 
bottles containing approximately 50-75 adult beetles on 5 grams of growth media 
(organic wheat flour with 5% w/w brewer’s yeast).  
Upon receipt of the shipment the containers were immediately inspected. No 
pupil, larval or egg stages of the organism were detected. Both samples were 
placed in two sterilized large mason jars with a wire mesh screen lid containing 10 
grams each of freshly prepared growth media (9.5 g. of pre-sifted organic whole 
wheat flash-frozen flour and 0.5 g. brewer’s yeast, % w/w). Each colony jar was 
42 
 
then placed in an incubating oven at 35° C under ambient humidity conditions. 
Documentation obtained from the KSU:TGP determined that these conditions were 
optimal for obtaining a maximum amount of the organism in the least amount of 
time necessary (15, 28). Under these conditions a single generation from eggs to 
adults will occur within 21 days. Each colony jar was inspected at least twice a day 
to maintain temperature and to determine overall well-being of the colonies.  
After approximately 2 weeks the colony jars were split, in which all adult 
beetles were removed and placed into new jars with 10 g. fresh media. The 
remaining jars, which now contain eggs and newly hatched larvae, are also 
maintained at 35° C under ambient humidity conditions and closely monitored. This 
cycle was repeated one additional time to produce 8 individual colony jars of either 
adults (4 jars) or eggs/larvae (4 jars) comprising 3 distinct generations. With a 
stable colony now established 2 of the adult colony jars were processed. All adult 
beetles were removed after egg-laying and larvae development was verified, placed 
into deep freeze vials and weighed then flash frozen over liquid nitrogen for 5 
minutes. These vials were then purged with nitrogen, sealed and labeled then 
placed under storage at -80° C until needed. Two jars of adults yield approximately 
2.5-3 g. total weight (or ~250-300 beetles).  
 
2.2.c.   General Extraction Method 
 The extraction and purification methods used for both organisms were 
previously or concurrently described by Farrell, et al., (21) Folch, et al., (29) 
Jeffries, et al., (12) and Sultana and Johnson (30), with only slight modifications.  
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 For the honeybees Apis mellifera, both farmed and feral, samples of each 
segment (2.5 g. heads, 5.0 g. thorax and 10.0 g. abdomen) were taken and placed 
in a mortar and pestle over ice with 1-5 g. clean sand and 1-5 mL of HPLC grade 
methanol. The sample was then ground into a uniform paste, diluted with additional 
methanol, allowed to settle from the sand and the remaining solution separated 
into centrifuge vials. This solution containing ground organism segment suspended 
in 10-15 mL of methanol was then placed on ice and ultra-sonicated for 20 minutes 
in 1 minute on/off cycles to further rupture and homogenize cellular material for a 
more extensive extraction. After sonication the solution was then briefly vortexed 
for 1 minute then centrifuged at ~10000xG for 5 minutes. The supernatant was 
then placed into large glass test tubes, capped with rubber stoppers, wrapped in 
aluminium foil and set aside. The remaining pellet was then re-suspended in 10-15 
mL of 1:1:0.1 of methanol:chloroform:water, ultra-sonicated on ice for an 
additional 10 minutes, briefly vortexed for 1 minute and centrifuged for 5 minutes. 
This secondary supernatant was then added to the first supernatant and set aside. 
The remaining pellet was re-suspended again using 5-10 mL. of a 2:1 
methanol:chloroform mixture containing 0.07 M KCl/0.11 M H3PO4 (stock 0.5 M 
KCl/0.8 M H3PO4), further ultra-sonicated on ice for 5 minutes, briefly vortexed for 
2 minutes and centrifuged for 10 minutes. The sample separated into three distinct 
layers: the bottom organic layer, a middle highly viscous interphase layer 
containing cellular material, and a top aqueous layer. The bottom organic layer was 
separated and added to the first two supernatant layers. All three layers, now 
combined, were dried overnight (~10-15 hours) under a steady stream of nitrogen. 
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The remaining residue under nitrogen was then either stored at -80° C until needed 
or immediately re-dissolved in 200 ul of N-hexane for subsequent purification. 
 For the red flour beetles the same extraction method was used with only 2.5 
grams total of the whole organism.  
 
2.2.d.    General Purification Method 
 The resultant residue from the extraction process is relatively crude and 
requires solid-phase extraction prior to any further analyses.  
 A small 10 mL. glass solid-phase extraction column with a porous frit was 
prepared using 0.5 g. of silica and a sand cap. This silica plug column was then 
rinsed with 2-3 mL of N-hexanes in preparation for the addition of the crude 
sample. The crude sample, re-dissolved in 200 ul. of N-hexane, was now carefully 
added to the sand bed and allowed to settle into the silica before addition of any 
further solvent. The crude sample was then washed and extracted using a mobile 
phase solvent gradient comprising of 4 mL. N-hexane, 1 mL (v/v) each of 99:1 
hexane:acetic acid, 90:10 hexane:ethyl acetate, 80:20 hexane:ethyl acetate, 70:30 
hexane:ethyl acetate, 2.0 mL of 2:1 chloroform:isopropanol and finally 1 mL. of 
methanol. Each gradient was collected separately in glass test tubes, capped and 
dried under nitrogen. The 70:30 hexane:ethyl acetate, cholorform:isopropanol and 
methanol fractions containing the extracted fatty acid amides were combined prior 
to drying. Each fraction sample was then stored under nitrogen at -80° C until 
further analysis. A total of 7 organism/body segments were used for the purification 
and extraction process: Farmed honeybee heads, thorax and abdomen; feral 
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honeybee heads, thorax and abdomen and whole-body red flour beetles. Each of 
these samples were extracted and purified individually and separately.  
 
2.2.e.    Preparation of Standards/Standard Curves and Blanks for Carry-Over and   
      Slip Additives 
 Standard molecules were grouped into 5 groups: acyl-dopamines, acyl-
glycines, acyl-serotonin, primary fatty acid amides and the internal standard D8-N-
arachidonoylglycine. The saturated/unsaturated N-acyl moiety lengths varied from 
C16 (palmitoyl), C18 (oleoyl, linoleoyl), and C20 (arachidonyl). Each compound was 
initially individually assayed to determine optimal concentration, retention times 
and expected ion patterns. For the use as a standard molecule to mimic an 
endogenous environment each compound was then combined into a dilution of 25 
uM in 1 mL HPLC-grade methanol (62.5 ug/mL, 0.025 nmoles on-column injection), 
including the internal standard. All standards were assayed in triplicate with 
retention time deviations less than 0.2 mins. prior to each assay elution profile for 
all sample sets. (12) 
For the purpose of standard curves used in quantitative analysis each 
compound was serial diluted to the range of 0.025 – 0.25 nM (0.0025-0.025 
nmoles injected on column). This range was determined to be the linear dynamic 
range of detection, with the lower limit being approximately 0.00125 nmoles 
injected on column due to significant scattering and the upper limit greater than 
0.025 nmoles injected on column due to a non-linear response curve. Additionally, 
each sample used for standard curve production included 0.025 nM of the internal 
standard to correct for any instrument and day to day usage deviations. Standard 
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curves for oleamide, palmitamide, palmitoleamide and linoleamide were done 
previously and only the slope of the linear region was available.  
Blanks for use in between HPLC-MS samples were prepared using 1.0 mL of 
pure HPLC-grade methanol assayed in triplicate. Sample blanks were also used 
prior to and after all assays were completed to flush the HPLC-MS system. To 
compensate for the presence of the slip additives oleamide and palmitamide 10 mL 
of HPLC-grade methanol was used in the same procedure as the extraction and 
purification method described herein, with 10 uL of the final concentrated sample 
diluted into 1 mL for HPLC analysis after the completion of all other assays.  
 
2.2.f.   HPLC-QTOF-MS and MS/MS Sample Analysis 
In preparation for analysis via mass spectroscopy each fraction was re-
dissolved in 100 µl. of HPLC methanol, from which 10 µl was then diluted into 1 mL. 
total of methanol spiked with 25 µm of the internal standard N-arachidonoylglycine-
d8 (1.50 µl at 170 µm). This internal standard was used to monitor and normalize 
instrument deviation in tandem with a calibration sample of only the internal 
standard assayed prior to all analyses. Additionally, a sample mixture of standard 
molecules at 25 µm in 1 mL. of methanol was also prepared and used during all 
sample analyses. Each organism/body segment sample is injected and analyzed 4 
times and is considered an endogenous sample set. Therefore, a total of 18 unique 
sample sets were used from farmed honeybees (5 heads, 7 abdomen, and 6 
thorax), 20 unique sample sets for feral honeybees (12 heads, 4 each abdomen and 
thorax) and 5 unique sample sets of red flour beetles (whole body). In total, data 
acquisition for the detection and quantification of endogenous fatty acid amides 
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produced about 200 individual data files from the organisms alone, not including 
standards, standard curve production, blanks and previous extractions and 
purification sample assays that did not yield results. Additionally, a sample of A. 
mellifera thorax extract was spiked with 25 pmols of pure standard mixture to 
determine extract matrix effects on retention time deviations and detection. 
 All sample analyses were performed on an Agilent 1260 HPLC system fitted 
with a Kinetex reverse-phase column (C18, 2.6 µm, 100 Å, 50 mm x 2.1 mm). The 
mobile phase comprised a binary mixture of Solvent A and Solvent B (water and 
acetonitrile, each with 0.1% formic acid, respectively) set to a linear gradient over 
time. Three time segments of this elution profile gradient over a total of 11.5 
minutes were programmed for all sample assays, with a 1 minute pre- and 2 
minute post-assay system flush. Time segment 1 was from 1-5 minutes with a 
linear increase of Solvent B from 10% to 100%. Time segment 2 was from 5-8 
minutes with an isocratic mobile phase of Solvent B at 100%. Time segment 3, 
from 8-9.5 minutes, returned the mobile phase to 10% of Solvent B. Flow rate 
throughout the analysis time was 0.6 mL/min at ambient temperature with a 
programmed pressure limit of 600 bar. Sample injection was 10 µl per sample with 
a draw speed of 100 µL/min and an eject speed of 200 µL/min. A needle wash of 3 
seconds with methanol was performed prior to sample injection into the HPLC 
system.  
All compounds of interest were determined to elute between 5 and 7 
minutes. To minimize mass spectrometer source contamination only this 5-7 minute 
portion of the analysis time was analyzed and recorded via MS. The remaining time 
periods were diverted to waste containment on the instrument and 
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chromatographic responses were not recorded in the majority of the samples used 
for quantitative analysis. 
 Mass spectrometric analysis of all samples was performed using an Agilent 
6540 Quadropole Time-of-Flight Mass Spectrometer coupled to the HPLC system. 
Ion source was a Dual Agilent Jet Stream Electrospray Ionization set to positive ion 
mode. Additional system parameters are as follows: Nitrogen source gas, 100-3000 
m/z range; 2.00 spectra/sec acquisition scan rate in extended dynamic range mode 
(2 GHz); 300° C. gas temperature; 8.0 l/min. gas flow rate; 35 psig nebulizer 
pressure; 350° C. sheath gas temperature; 11 l/min. sheath gas flow rate; 3500 
Vcap; 1000 V nozzle voltage; 175 V fragmentor and 65 V skimmer. Internal 
reference samples inherent to any analysis performed with this instrument occurred 
at +121.05087300 and +922.00979800 m/z. System calibration and auto-tuning 
was performed prior to any and all analysis. 
 For the purpose of confirming the presence of endogenous eCBs both AEA 
and OEA standards, and both A. mellifera and T. castaneum extracts, were used for 
targeted tandem mass spec-mass spec product ion analysis. Each sample was 
prepared as previously described herein. Pure standard of AEA was used to 
determine the optimal collision energy for product ion fragmentation and the 
retention time prior to determining the endogenous presence of AEA in both 
organism extract samples. Optimal collision energy was experimentally determined 
to be 25 eV, with testing also performed at 15 eV for AEA, and retention times of 
approximately 5.6 and 6.0 minutes for AEA and OEA, respectively. OEA was spiked 
into both organism extract samples to determine assay functionality and 
confirmation of the retention time within each extraction matrix. Only the 
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endogenous AEA was assayed in A. mellifera thorax and T. castaneum whole body 
extracts. Parent-to-product ion fragmentation of AEA was m/z 349.18  62.06 and 
for OEA m/z 324.98  62.06. 
 Prior to sample assays and after completing all assay elutions a column flush 
program was used to remove any contamination, standard molecule carry-over and 
slip additives from the column. This program consisted of the previously described 
method herein using an extended solvent linear gradient and isocratic period 
totaling 20 minutes (10 minutes each), with all solvent elution diverted to waste. 
This flushing program was performed in duplicate.  
 
2.2.g.   Sample Data Analysis – Qualitative Identification 
 Each sample injection produced a Total Ion Count (TIC) chromatogram, 
showing the full response of all detected ions within the 100-3000 m/z range for 
the recorded time period, as an individual data file with an appropriate name to 
reflect the organism/body segment, date and replication number. These individual 
files were then analyzed using Agilent MassHunter qualitative analysis v. B. 05.00 
software.  
 All analyzed endogenous samples were compared to both the chromatogram 
retention times and mass spectrometer ion results of known pure standards 
acquired from Caymen Chemicals, Inc. assayed concurrently with each sample 
series. Acceptable variances for comparisons in terms of retention time and m/z 
were determined to be ±0.2 minutes and ±25.0 m/z. Additionally, dopamine and 
serotonin derivatives are known to produce oxidized compounds in solution and in 
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contact with atmosphere. These quinones should also be determined and, if any are 
detected, added to the total amount of the reduced form of the molecule.  
 Endogenous determination of each molecule was determined using the 
following method with the Agilent MassHunter software, based on initial 
determinations from the first set of standards using procedures contained within 
the software, optimized based on greater usage and understanding of the software 
and principles of mass spectroscopy.   
 After executing each sample injection data file the molecular formula for the 
respective molecule of interest was input into the Find by Formula- Options tab 
located under the Find Compounds by Formula section of the Methods Explorer 
menu. The Matches per Formula option was set to 3, with the option to match for 
isomeric compounds turned on. Match tolerances were set to ±100 ppm masses 
and ±0.35 retention time. Expansion of values for chromatographic extraction was 
set to systemic ±35.0 ppm with limited EIC extraction range left to default values. 
The expansion values were varied as needed to obtain optimal results as 
determined by the known standard analysis as this often varied by molecule. 
Positive ions were set to H+ and Na+ only. Settings under the Results tab were left 
to default values, ensuring that Extract EIC and Extract clean spectrum are marked 
as on. Under the Results Filter tab all options were marked off except the option to 
only match formulas to generated compounds. After confirmation of these options 
the operation was executed by selecting all of the relevant samples in the 
subsequent menu. The results produced is the individual Extracted Ion Count 
chromatograms (EIC), a sortable table of the EICs showing the area of the peak(s) 
for the compound with retention times, and various other values, with a 
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corresponding mass spectrogram showing the ion and isotope distribution for each 
EIC. The table is then sorted by retention time, highlighting the standards used, 
and any EICs listed outside of the acceptable variance are removed. In the event 
that the standards produce multiple EICs of various retention times only those EICs 
with similar retention times to the original standard sets assayed, and those with 
the expected higher peak areas, were used with all others disregarded. These 
disregarded results for the standards are considered on-column contaminants 
and/or molecules similar enough to match the given formula within the 
programmed tolerances. The remaining EICs and mass spectrograms are then 
compared to the standard. Ion and isotope abundance are compared in the context 
of the acceptable tolerances set as well as the overall “spread” of the isotopic ion 
abundance. Systemic variances of these spectrograms are endemic to this process 
due to the overall crude and complex nature of the endogenous samples as well as 
the oxidation of some of these molecules. (12, 22, and 31).  Further details will be 
discussed in later sections below. As an additional cross-reference between 
potential endogenous samples and the standards a comparison of the target mass-
to-charge ratio difference should also be taken into account. Finally, the software 
also outputs a Score value which takes into account several variables including 
target m/z differences, predicted ion masses and isotopic abundance pattern. Due 
to these parameters, this value is highly dependent upon sample purity and 
concentration and should not be readily considered for determination of compound 
identification. However, a high Score value, in conjunction with an acceptable 
retention time as compared to the standard, does not necessarily detract from a 
positive identification of a compound. (12) 
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 After a sample series is identified as an endogenous compound the file is 
then saved as a tab delimited Excel file from the Export option ensuring that 
retention time and peak area are stored. This file can then be copy and pasted into 
an existing Excel file for further data analysis and calculations.    
 
2.2.h.   Sample Data Analysis – Quantitative Analysis 
 After qualitative identification of the sample series is complete and all 
relevant data is stored and sorted, the area for each compound determined is then 
calculated into a corresponding endogenous amount within the organism/body 
segment. 
 For each sample series confirmation of the internal standard of N-
arachidonoylglycine-d8 must be determined prior to any quantitative analysis as 
well as a compound’s corresponding standard curve. Each endogenous sample 
series average area of the curve must be adjusted using the internal standard 
average area of the curve present in the sample series with a pure sample injection 
of the internal standard. First, the average area of the curve for the internal 
standard co-injected with the endogenous sample is weighted against an injection 
assay of the pure internal standard prior to any endogenous samples for that day’s 
analyses. This ratio of pure internal standard to co-injected I.S. is then multiplied 
into the average and standard deviations of all endogenous compound area of the 
curves. This is done to compensate for day-to-day instrument deviations, potential 
changes in column conditions and other similar variables such as solvent changes, 
variances in temperature, etc. For any oxidation products detected in the acyl 
dopamine series the area of the curve for the quinones are added to the area of the 
53 
 
reduced molecule prior to this correction, though are generally negligible when 
detected. 
 The compensated averages and standard deviations are then calculated into 
corresponding pmol/gram amounts using the slope of a standard curve for the 
corresponding compound. This calculation is determined prior to any analysis and is 
a series of stoichiometric conversions using the amount of the sample diluted for 
injection, the total volume diluted into, the calculated amount delivered to the 
column, the amount of the organism/body segment used for the sample and finally 
the slope of the standard curve. In general mathematical principles, all of these 
calculations can be summed into one value that is then divided by the slope and 
multiplied by the corrected average of the area of the curve for the endogenous 
compound. (12, 17, 21) This calculation is repeated for the standard deviation as 
well. Both values are in pmol/gram of organism. Care must be taken to ensure that 
these calculations are correct. An example of a data set and the calculation process 
is shown in Figure 2.3 below. 
Finally, after each sample series is calculated into an average pmol/gram ± 
S.D. value these averages are further averaged together based on the total number 
of sample series’ assayed, with any on-column contamination amounts subtracted 
out using the same methods applied to the corresponding blanks assayed in 
between each sample series. The resultant aggregate average and standard 
deviation now reflects the final endogenous amounts of the corresponding 
compound detected. 
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Figure 2.3: Example data set taken directly from results file (OEA, Tribolium) and 
an example calculation for the quantitative analysis of OEA used for all endogenous 
endocannabinoids/fatty acid amides. This same calculation is used for the standard 
deviation of pmol/gram and for the carry-over/contamination amounts if detected, 
which are subtracted from the average pmol/gram. 
  
 
2.2.i.   Sequence Homology with D. melanogaster AANAT 
 Expression of fatty acid amides endogenous to A. mellifera and T. castaneum 
requires the existence of arylalkylamine N-acyltransferases (AANATs) such as those 
previously determined within Drosophila melanogaster. (17) Utilizing the NCBI 
D8-NAG 373000000 Blanks 33991
C22H27D8NO3 OEA 49365
RT =5.7 C20H39NO2 16519
Std 193693 326.3,327.3 13836
220561 RT =5.9 28773
193306 28496.8
199244 14354.02
avg 201701 Avg 3.1
S.D 1.5
D8 OEA D8 OEA D8 OEA D8 OEA D8 OEA
6.12 576215 289080 6.11 152504 12938 6.11 A 161391 12931 6.11 B 221110 31256 6.11 C 136139 17801
519932 274425 153136 14501 144256 12088 178403 33159 133453 15714
438249 244082 145915 14738 141792 13300 136422 26155 165551 12267
299239 134886 97229 14037 128876 12119 150179 23829 165551 13360
645015 219384 146837 13984 201984 14351 165215 20106 136098 15139
avg 495730.0 92948.6 Avg 139124.2 20357.42 Avg 155659.8 16845.14 avg 170265.8 31743.18 avg 147358.4 20352.99
Correction 0.4 24325.8 1.45 1003.876 1.30 1219.328 1.18 6307.603 1.37 2940.734
Avg 99.68 21.83 18.06 34.04 21.83
S.D 2.61 1.08 1.31 6.76 3.15
Total of all 
determinations
36.0 Avg
7.9 S.D
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database (http://www.ncbi.nlm.nih.gov/), sequence homology comparisons 
between the known D. melanogaster NAT CG9486 (NP_609005.1) with possible 
NATs in both A. mellifera (taxid: 7460) and T. castaneum (taxid:7070). An online 
protein BLASTp sequence analysis using the NCBI database software of CG9486 
with these organisms produce homology sequences with two isoforms of dopamine 
N-acetyltransferases in both organisms, NP_001139380.1 and NP_001139379.1 
(Tribolium isoforms 1 and 2, respectively); XP_392876.2 and XP_006566050.1 (A. 
mellifera isoformX1 and X2, respectively). All sequence comparisons showed 
greater than 30% identity with coverage greater than 93%. Additionally, sequence 
comparison of protein residues was also performed showing conserved residues 
between all three organisms. (17) MEME motif studies were conducted by uploading 
the above amino acid sequences into the MEME tool located at 
http://meme.nbcr.net/meme/ and exporting as an htmL document. 
 
2.3  Results and Discussion 
 
2.3.a.   Standard Samples, Standard Curves and Spiked Standards in Apis  
       mellifera Thorax 
The N-acylated derivatives of ethanolamines (NAEs), dopamines (NADs), 
serotonin (NOSt), glycines (NOGly) and primary fatty acid amides (PFAAs) 
investigated in this study are summarized in Table 2.2 above. Stated retention time 
is the average from all standard mixes assayed concurrently with each sample 
series, including any oxidation side-products when detected. Assays of individual 
separate standards is not shown, as these were not indicative of the molecules 
within the endogenous sample series tested due to matrix effects (dynamic sample 
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mixture, solvent effects, precipitation, etc.) and other uncontrollable and unknown 
conditions. 
Table 2.2. Summary of standard molecules used. Included is the abbreviated name, 
average retention time ±0.2 minutes, mass-to-charge ratio of the proton and 
sodium adducts and the molecular formula. Also included are the known possible 
oxidation products, when applicable. 
 
N.D. is not detected with adequate reproducibility 
 
 Only the standards as a total mix were used to best mimic the complex 
matrix environment of the endogenous samples. The stated mass-to-charge ratios 
are that for the protonated ionized parent molecule, [M+H]+, and that of the 
sodium adduct of the ionized parent molecule, [M+Na]+, respectively. These values 
are derived directly from the standards of these molecules as observed.  
 Construction of the standard curves proceeded as previously described. 
Examples of these standard curves, and the corresponding mass spectral results, 
are presented below for the internal standard D8-NAG (Fig. 2.4). All other standard 
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curves and mass spectral results are presented in the appendix of this chapter. 
Documented retention times for each standard sample shown are within the 
aforementioned ±0.2 minute tolerance, with the average retention time for each 
compound labeled within the graph. Percent error of the standard curves is less 
than 5% for each data point shown. X-axis intercept values are not shown as each 
sample gave values less than 10% of the calculated slope and thus would calculate 
outside of the acceptable limits of significant figures. Calculated slope values shown 
all provided R2 linearity values >0.95. Mass-to-charge ratio values for both proton 
and sodium adducts are within 25 ppm of the expected values per those calculated 
via the software. The presence of oxidation products in the N-acyldopamine series 
is also compensated for, as previously discussed in the methods portion. 
 Standard curves for the primary fatty acid amides are not shown and slope 
values were provided by Jeffries, et al., (12) using the same assay methods, stock 
samples and column. Only the individually-assayed standards are provided 
(Appendices). 
In an effort to control for matrix effects, cellular oxidation and other variables 
due to assaying relatively impure and highly complex mixtures from these 
organisms, a brief series of controlled spiked samples were performed (OEA 
example, Figure 2.5). Two sample sets of farmed A. mellifera thorax were 
extracted and purified with the addition of known amounts of OEA, AEA, NAD and 
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NOG added at the beginning of the extraction process. An additional sample series 
included these compounds just prior to purification only. Each set was assayed as 
described previously then compared to the standard mix of these compounds that 
were concurrently assayed. Only the samples spiked prior to extraction is shown, 
as the samples spiked prior to purification did not complete the assay process 
correctly (data not shown), likely due to high concentrations saturating instrument 
detection or instrument error and time constraints.  Side-by-side comparisons of 
the spiked samples with the standard mix clearly shows a pattern of retention time 
deviation within the acceptable tolerance of ±0.2 minutes, likely due to the 
aforementioned matrix effects, instrument variation and column conditions. 
Additionally, these results also show changes in the detected m/z values and the 
changes on ion distributions, likely a result of decreased concentration directly 
affecting instrument analysis and computation of those values. Such errors and 
limitations were proven to be highly pervasive within the entirety of the data 
collected. Suggestions for the mitigation or elimination of these errors include use 
of a column in better condition and more extensive sample clean-up prior to 
assaying. Column/instrument contamination and compound cross-over of previous 
samples also occurred, likely also due to the complex nature of the extracted 
samples and instrument limitations 
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Figure 2.4. Example Standard Curve and MS results for D8-NAG I.S.  
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2.3.b.   Endogenous Results – Farmed and Feral A. mellifera 
 
Table 2.3. Summary of quantitative results for eCBS/FAAs in farmed A. mellifera. 
Amounts are reported as average ± S.D in pmol/g. of organism from 20 individual 
assays of heads, 28 from thorax and 24 from abdomen. 
 
*Compound not detected with adequate reproducibility 
 
Table 2.4. Summary of quantitative results for eCBs/FAAs in feral A. mellifera. 
Amounts are reported as average ± S.D in pmol/g. of organism from 48 individual 
assays of heads and 16 each from thorax and abdomen. 
*Compound not detected with adequate reproducibility 
Molecule Heads Thorax Abdomen
N- Oleoylethanolamine 30 ± 8 6 ± 7 437 ± 122
N- Arachidonoylethanolamine 41 ± 3.0 6 ± 5 10 ± 6
N-Palmitoyldopamine 4 ± 0.5 11 ± 9 26 ± 10
N- Oleoyldopamine * 19 ± 6 28 ± 9
N- Arachidonoyldopamine * * *
N -Palmitoylglycine 125 ± 41 16 ± 9 52 ± 18
N- Oleoylglycine 31 ± 1 6 ± 2 4 ± 2
N- Arachidonoylglycine 25 ± 3 14 ± 3 3 ± 1
 
N- Oleoylserotonin * * *
Linoleamide 0.2 ± 0.5 11 ± 6 44 ± 15
Palmitoleamide 143 ± 200 114 ± 83 356 ± 288
Palmitamide 17 ± 5 12 ± 5 20 ± 13
Oleamide 179 ± 43 51 ± 15 85 ± 37
Farmed A.M.  (pmol/g)
Molecule Heads Thorax Abdomen
N- Oleoylethanolamine 35 ± 16 31 ± 16 1918 ± 110
N-Arachidonoylethanolamine 27 ± 18 17 ± 9 *
N- Palmitoyldopamine 76 ± 29 20 ± 21 140 ± 6
N- Oleoyldopamine 46 ± 24 * *
N-Arachidonoyldopamine * * *
N -Palmitoylglycine 36 ± 29 50 ± 29 220 ± 72
N-Oleoylglycine 32 ± 4 18 ± 14 32 ± 14
N-Arachidonoylglycine 12 ± 7 * 21 ± 9
N-Oleoylserotonin 45 ± 26 59 ± 38 362 ± 170
Linoleamide 45 ± 21 24 ± 25 153 ± 39
Palmitoleamide 398 ± 141 911 ± 389 1423 ± 639
Palmitamide 127 ± 19 13 ± 6 80 ± 12
Oleamide 163 ± 57 948 ± 634 438 ± 164
Feral A.M.  (pmol/g)
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Samples for the detection of the endogenous eCB/FAAs proceeded as 
previously described with the awareness of the aforementioned limitations observed 
with the standards and spiked assays. Sample reproduction yielding results within 
acceptable values was difficult to acquire and is again likely due to the 
aforementioned limitations. Attempts at mitigating these errors and limitations 
provided limited success. The total number of assayed samples for the entirety of 
this study was prohibitively high (>200) considering the nature and preparation of 
the samples and the instruments used. 
 For clarity, the aggregate of all body segments from farmed A. mellifera is 
shown as an overlapping spectrum per each compound, with select mass spectral 
results shown also for clarity. All utilized data was comparable however for detected 
molecules. Several examples are shown in Figures 2.6-2.8, with the remaining 
supplied in the appendix of this chapter.  
 Reproducible results, or sufficient results to provide a statistically acceptable 
value, were unobtainable for NAD in all body segments for both farmed and feral A. 
mellifera. Any detected results were likely due to anandamide “shadow” peaks. 
Therefore, the endogenous detection of this compound is inconclusive in both 
groups of this organism. It is unlikely that the similarity of these results is due to 
direct environmental or genetic differences between the two groups; rather it is 
more likely that NAD exists below the detectable threshold of the assay technique 
and instrument. Overall concentration of NAD within each organism may vary due 
to unknown factors at the time of collection. An example of such a variable may be 
body temperature, as it has been speculated that NAD may be part of body 
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temperature regulation in other animals, though no evidence to date thus far 
suggests this is the case in insects. Another factor is that NAD in low endogenous 
concentrations may have readily oxidized to the quinone/indole forms, aggregated 
and precipitated out either during the extraction and purification process or prior to 
assaying of the diluted samples, thus preventing reliable and reproducible detection 
by mass spectroscopy. Without a reliable method of measuring and quantifying this 
oxidation phenomenon overcoming this limitation using these techniques is difficult 
at best. One method that could provide quantifiable results would be the use of an 
oxidizing agent such as sodium periodic acid with known amounts of heavy-labeled 
compounds in vitro then analyzed via mass spectroscopy. (22) However, periodic 
acid usage in HPLC-MS systems is generally unacceptable do to damaging the 
instrument.  
 NOSt was undetected in all three farmed body segments, unlike in the feral 
body segments as presented in Table 2.4. The reasons for this discrepancy is 
similar to those discussed for NAD, though the nature and function of NOSt is 
currently unknown in insects and may or may not be related to direct 
environmental or biological factors, such as body temperature regulation as posited 
for NAD. Serotonin is known to be a digestive system signaling and mediation 
neurotransmitter in higher animals, such as mammals, and has only very recently 
been determined to have similar roles in A. mellifera. (32) Since the highest 
detected levels of NOSt from this study is in the abdomen (362 ± 170 pmol/g), 
such data is therefore plausible. Concurrently, Verhoeckx and colleagues have 
detected endogenous levels of N-acylserotonin within mice and pigs primarily 
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localized in the intestine. Their data suggests direct links to the endogenous levels 
of these molecules with serotonin and a diet supplemented with fatty acids. (33) 
Such research further sheds light, and lends strong evidence, to the currently 
proposed biosynthetic and degradation pathways having been mentioned, 
specifically the direct conjugation of fatty acids to fatty acid amides and the 
degradation/regulation via FAAH (Figs. 1.3-1.5). An additional source for this 
discrepancy may also be the existence of microbiota within or on the feral 
honeybees which may be contributing to these endogenous levels. Much of the 
recent work with N-acylserotonins is providing very promising and exciting results 
within the field of endocannabinoid research.  
 In general, a strict comparison of the endogenous levels of the remaining 
compounds gives comparable results within an acceptable order of magnitude. 
Much of the variations shown for many of these molecules can generally be 
attributed to factors including variability in the extraction and purification process, 
instrument variation, and unknown biological factors contributing to the expression 
of these compounds in vivo. N-oleoyldopamine, however, in comparison between 
farmed and feral A. mellifera does show discrepant results. Between farmed and 
feral groups the overall detection of NOD in specific body segments is not 
consistent. For farmed bees NOD is detected with sufficient reproducibility in thorax 
and abdomen, while being absent or inconsistent in the heads. In contrast, the 
opposite results occurred for the feral population. It is generally assumed such 
discrepencies with N-acyldopamines specifically is due, at least in part, to their 
predilection for oxidiation to polymeric structures which are difficult to detect and 
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quantifiy. (22) Additionally, because of the inherently high deviations from the 
methods employed such discrepancies in detection can be expected. Exceptions 
would be any recurring patterns such as these occurring in other compounds 
between the two populations. Indeed, these high deviations in detected levels are 
higher than the average levels calculated. An example of this is the primary fatty 
acid amides in both farmed and feral populations. As such it is debatable whether 
these endogenous values are indeed valid. However, the PFAAs are generally 
considered a separate class of molecules that have been extensively researched in 
their own right and are tangentially related to the eCBs/FAAs in the scope of this 
work. PFAAs presented herein are shown for the purpose of giving context and 
broader relevance whilst connecting to established endogenous molecules. 
Additionally, specific PFAAs, such as Oleamide and Palmitamide, are known slip-
additives in many laboratory plastic-ware and must be compensated for, as 
described previously. (26, 25) 
A final note on the quantification of the endogenous eCB/FAA levels using 
standard curves are variations in the column and instrument over time between the 
measurement of the standard curves and the measurement of the endogenous 
levels. System response and column conditions are likely to change with extensive 
usage, therefore a strict comparison of the response for standards with endogenous 
levels over a separated period of time are increasingly likely to show deviation. 
Generally speaking, standard curves should be repeated every three to six months, 
depending on usage, to further compensate for such deviations. At the time of the 
endogenous assays the provided standard curves were nearing the six month 
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limitation. Repeating the standard curves was not possible due to lack of access to 
the HPLC-QTOF/MS upon completion of the endogenous assays. 
 The determination of these compounds being truly endogenous to these 
organisms would not be complete without a tandem mass spectroscopy assay. A 
targeted MS/MS assay is employed to show the expected product ion fragmentation 
from a given parent ion, such as [M+H]+. For this purpose, a targeted MS/MS 
comparative study between standard anandamide, spiked OEA and endogenous 
anandamide was conducted in A. mellifera thorax. Standard AEA was used to 
determine the retention time (~5.6 minutes) and optimal fragmentation voltage 
(25 eV) using the standard assay techniques described previously. OEA was used in 
conjunction as a spiked standard for the same purpose and to observe any potential 
deviations due to matrix effects, etc. (~6.0 minutes, 25 eV). Both compounds gave 
the expected product ion fragment of m/z 62 corresponding to the ethanolamine 
fragment (Fig. 2.9 and 2.10). The remaining fragments, long-chain aldehydes of 
m/z 289.2 and 267.2 for AEA and OEA respectively, are likely either obscured 
during detection by other background ions or exist as uncharged species. Though 
not predicted, the fragment at m/z 287.2 may be this remainder existing as an 
[M]+ species.  
 Though limited, these results are fairly indicative of the endogenous nature 
of the eCBs/FAAs described within this study and provides some validation of these 
results in the Apis mellifera species.  
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Figure 2.6. Aggregate spectra and MS results of endogenous OEA and NPD in 
farmed A. mellifera. 
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Figure 2.7. Aggregate spectra and MS results of endogenous acyl glycine NPG and 
Palmitamide in farmed A. mellifera. 
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Figure 2.8. Aggregate spectra and MS of suspected endogenous N-oleoylserotonin 
in both farmed and feral populations of A. mellifera. 
. 
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Figure 2.9. Targeted MS/MS spectra of standard AEA at 15 eV collision energy 
showing the absence of the expected product ion fragment, m/z 62.06. Targeted 
MS/MS spectra of standard AEA at 25 eV collision energy showing the presence of 
the expected primary product ion fragment, m/z 62.06 and corresponding decrease 
in the parent ion, m/z 348.2. Inset shows the predicted fragmentation pattern for 
AEA.  
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Figure 2.10. Targeted MS/MS spectra of AEA in A. mellifera extract at 25 eV 
collision energy showing the expected primary product ion fragment, m/z 62.06, 
and targeted MS/MS spectra of spiked OEA in A. mellifera extract at 25 eV collision 
energy showing the same expected product ion fragment. Inset shows the 
predicted fragmentation pattern for AEA and OEA, respectively.  
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2.3.c.   Endogenous Results – T. castaneum 
 
Table 2.5. Summary of quantitative results for eCBs/FAAs in T. castaneum. 
Amounts are reported as average ± S.D in pmol/g of organism from 20 individual 
assays of whole bodies.  
 
*Compound not detected with adequate reproducibility 
 
 As for the honeybees, samples for the detection of the endogenous eCB/FAAs 
in T. castaneum proceeded as previously described with the awareness of the 
aforementioned limitations observed with the standards and spiked assays. Sample 
reproduction yielding results within acceptable values was equally as challenging for 
T. castaneum as it was for A. mellifera; again likely due to the aforementioned 
limitations. Attempts at mitigating these errors and limitations provided limited 
success for T. castaneum as well. The total number of assayed samples was also 
prohibitively high (>30) considering the nature and preparation of the samples and 
the instruments used, though not as high as compared to A. mellifera due to the 
beetles being whole body extracts and not three separate segments.  
 For clarity, the aggregate of all assays for each molecule from T. castaneum 
is shown as overlapping spectra, with select mass spectral results also shown for 
Tribolium  (pmol/g)
Molecule Whole Body
N-Oleoylethanolamine 36 ± 8
N- Arachidonoylethanolamine 42 ± 24
N-Palmitoyldopamine 53 ± 25
N- Oleoyldopamine 21 ± 6
N-Arachidonoyldopamine 26 ± 14
N -Palmitoylglycine 25 ± 12
N-Oleoylglycine 16 ± 9
N- Arachidonoylglycine 18 ± 17
N- Oleoylserotonin *
Linoleamide *
Palmitoleamide 178 ± 83
Palmitamide 53 ± 37
Oleamide 102 ± 45
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clarity. All utilized data was comparable however for detected molecules. Several 
examples are shown in Figures 2.11-2.12, with the remaining supplied in the 
appendix of this chapter. 
 Reproducible results, or sufficient results to provide a statistically acceptable 
value, were unobtainable for NOSt in T. castaneum and is inconclusive for this 
molecule. Like A. mellifera, it is unlikely that the inability to adequately detect and 
quantify NOSt is due to any environmental or biological issue, but rather is likely 
due to the endogenous levels existing below the detectability limit of the 
instrument. Another potential factor, like that of NAD, is that NOSt in such low 
endogenous concentrations may have readily oxidized to a form similar to the 
quinones/indoles produced by N-acyldopamine oxidation. If so, NOSt may have 
aggregated and precipitated out either during the extraction and purification 
process or prior to assaying of the diluted samples, thus preventing reliable and 
reproducible detection by mass spectroscopy. Similarly, without a reliable method 
of measuring and quantifying this oxidation phenomenon overcoming this limitation 
using these techniques is difficult at best. The suggested method as described for 
the NAD, the use of periodic acid to induce oxidation of heavy-labeled compounds 
in conjunction with HPLC-MS, is again generally unacceptable do to damaging the 
instrument. 
Additionally, the detected levels of NAG, 18 ± 17 pmol/g, suggests that this 
compound may not exist endogenously, statistically-speaking. It is likely that NAG 
does exist endogenously in comparison to A. mellifera and also by taking into 
account that the detected value for NAG does not follow the observed trend in the 
data for the other molecules present. The cause for such an outlier is suggested to 
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be similar to the absence of NOSt, that being low endogenous levels existing below 
the detection limit of the instrument in conjunction with various other limitations 
aforementioned.  
The data collected for Linoleamide was inconclusive due to any endogenous 
values having been subtracted out when compensating for carry-over and/or the 
existence of slip additive determined from control samples.  
 Unlike honeybees however, the presence of NAD is detected and measured in 
the red flour beetles (26 ± 14 pmol/g). Such data may suggest that the levels of 
NAD are higher in this organism than in A. mellifera for it to be at such a detectable 
level.  
In general, a strict comparison of the endogenous levels of all assayed 
compounds gives comparable results within an acceptable order of magnitude, with 
relatively low deviations in comparison to the results presented for A. mellifera.  
Again, variations shown for many of these molecules can generally be attributed to 
factors including variability in the extraction and purification process, instrument 
variation, and unknown biological factors contributing to the expression of these 
compounds in vivo.  
It should be noted that the statistical variations of the data as a whole, with 
the exceptions previously noted, is comparatively low to that of A. mellifera (and to 
a lesser degree the results published for D. melanogaster by Jeffries, et al.). A 
likely cause for these comparatively positive results to A. mellifera is that all assays 
used to derive these values were conducted during the same assay session in a 
relatively short time span (6-8 hours for Tribolium versus 12-14 hours for 
Mellifera). In the context of the prior argument that the deviations of these values 
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are in part due to possibly outdated standard curves, and to day-to-day instrument 
variations, these results suggest that instrument variation has a greater impact.  
 As for A. mellifera, confirmation of the endogenous nature of these molecules 
requires a targeted MS/MS assay. Similar to that performed for A. mellifera, spiked 
OEA and endogenous AEA were studied using the aforementioned MS/MS technique 
in Tribolium whole-body extract. Standard AEA was again used to determine the 
retention time (~5.6 minutes) and optimal fragmentation voltage (25 eV) using the 
standard assay technique. OEA was used as a spiked standard for the same 
purpose and to observe any potential deviations due to matrix effects, etc. (~6.0 
minutes, 25 eV). Both compounds gave the expected product ion fragment of m/z 
62 corresponding to the ethanolamine fragment (Fig. 2.13). The remaining 
fragments, again long-chain aldehydes of m/z 289.2 and 267.2 for AEA and OEA 
respectively, are likely either obscured during detection by other background ions 
or exist as uncharged species, just as in the A. mellifera MS/MS results. Also 
similar to A. mellifera results, the fragment at m/z 287.2 may be this remainder 
existing as an [M]+ species.  
 For T. castaneum, these results are fairly indicative of the endogenous 
existence of the eCBs/FAAs described within this study and provides validation of 
these results in the T. castaneum species. 
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Figure 2.11. Aggregate spectra and MS of endogenous OEA and the acyl dopamine 
NOD in T. castaneum. 
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Figure 2.12. Aggregate spectra and MS of endogenous the N-acylglycine, NOG, and 
of the PFAM Palmitamide in T. castaneum. 
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Figure 2.13. Targeted MS/MS spectra of endogenous AEA in T. castaneum extract 
at 25 eV collision energy showing the expected product ion fragment, m/z 62.06, 
and of spiked OEA with the same expected product ion.  
 
 
  
H2N
OH
O
N
H
OH
O
+
2-aminoethan-1-ol
m/z [M+H]+: 62.05 (100.0%),
63.06 (2.3%)
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal
m/z [M+H]+: 289.25 (100.0%), 290.25 (22.0%), 291.25 (2.5%)
Anandamide (AEA)
m/z [M+H]+: 348.28 (100.0%), 349.29 (24.3%), 350.29 (3.2%)
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2.3.d.   Genetic Homology Study of AANAT between D. melanogaster, A. mellifera  
  and T. Castanaeum. 
 The final portion of this research into the existence and quantification of the 
endogenous endocannabinoids/fatty acid amides is a brief genetic study into the 
existence of a putative arylalkylamine N-acyltransferase within both T. castaneum 
and A. mellifera. An AANAT recently discovered and shown to produce the requisite 
chemistry in D. melanogaster (17) is compared to two similar homologs in both 
organisms using the NCBI database BLASTp tool as described previously (Fig. 
2.14). From the sequence comparison of the protein residues several conserved 
regions were detected, showing significant sequence homology between all three 
organisms. Furthermore, to aid in this comparison, a motif-sequence analysis study 
of AANAT homology using MEME Suite (Multiple EM Motif Elucidation, 
http://meme.nbcr.net/meme/) was also conducted on the truncated forms of these 
AANATs from all three organisms (Fig. 2.14, lower portion). These motifs are the 
protein sequence regions predicted to produce distinct secondary structures of a 
fully transcribed mature and active enzyme. (34) This prediction goes beyond 
simple residue sequence comparison by adding a second layer of homology 
determination between these enzymes. Additionally, motif prediction can determine 
if an already-known catalytic site shares both sequence homology and secondary 
structure homology, such as in the case of the AANAT from D. melanogaster 
(wherein the Glu-47 residue was shown to be essential in the catalytic site) (35), as 
it is the secondary structure that is key to the enzyme’s function. As can be seen in 
Figure 2.14 there is significant sequence and corresponding motif homology 
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between all four of the AANATs, as compared to the now known AANAT from D. 
melanogaster. 
Figure 2.14. Top: Protein residue sequence homology of AANATs showing conserved 
residues/domains between D. melanogaster, DM, with A. mellifera isoforms, AM1 
and AM2, and T. castaneum isoforms, TC1 and TC2. Bottom: Comparison of 
sequence homology in the context of predicted secondary structure motifs between 
T. castaneum, A. mellifera and D. melanogaster AANATs (specifically dopamine N-
acyltransfereases). Height of each motif block indicates relative homology between 
each organism.  
  
81 
 
2.4  Conclusions and Recommendations 
 Because of the recent completion of genome sequencing for both the 
honeybee (Apis mellifera) and red flour beetle (T. castaneum) their use as new 
model organisms are now feasible, within limitations. In conjunction, the 
environmental, agricultural and potential human impact of these organisms has 
made research such as this vital in recent years. With the recent discovery of 
endocannabinoids and fatty acid amides in Fruit flies, and a likely enzyme in the 
biosynthetic process, research into the endocannabinoid system (or the 
“endocannabinome”)  of insects is now of growing interest. To that end, this work 
set out to identify and quantify the eCBs/FAAs in these two novel organisms in 
conjunction with a brief genetic comparison using the known Fruit Fly enzyme 
shown to conduct the requisite biosynthetic production of these molecules.   
 Based on the results presented within this work, though limited, there is now 
fair evidence to support the theory that (a) the eCBs/FAAs are indeed endogenous 
molecules within these two additional insect species as compared to Fruit flies and 
(b) genetic comparison studies show that a known biosynthetic enzyme very likely 
does exist within these insects to produce these molecules.  
 With the discovery of the Fruit Fly AANAT, and the homology of the AANAT 
within mellifera and Tribolium, a specific biosynthetic pathway can thus be 
proposed, as presented in Figure 2.15 below using N-acyldopamine as an example 
based on Chapter 1.  
 Additionally, a new hypothesis for the in vivo/physiological activity of the 
NADs based on their known quinone/indole oxidation products is now proposed. 
Due to the similarities of these quinone/indole products to serotonin, the observed 
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effects of the NADs as have been presented may be due to these quinone/indole 
forms and not the reduced form of the N-acyldopamines. If so, the observed levels 
of activity may not fully reflect the actual physiological amounts and may actually 
be significantly higher. If true, the physiological impact and significance of the 
NADs may also be higher. 
Figure 2.15. The proposed key step in the biosynthesis of an N-acyldopamine 
endocannabinoid/fatty acid amide based on AANAT sequence and motif homology 
for D. melanogaster, A. mellifera and T. castaneum.  
 
 
Recommendation for further research as a continuation of this work includes 
refining the quantification of the endogenous levels, performing a heavy-labeled 
fatty acid/fatty acid-coA feeding study, RNAi or AANAT gene expression knockout 
with Tribolium, and the expression, purification and kinetic evaluation of Tribolium-
derived AANAT and FAAH from e. coli. The apparent absence of known receptors for 
these molecules in insects also must be addressed. 
Refining the endogenous levels of the eCBs/FAAs in both organisms should 
proceed with a separate column isolated from any other use, preferably utilizing 
ion-trap mass spectroscopy in order to “pool” the ions for better quantification and 
further MS/MS studies using other fatty acid amides. 
Heavy-labeled fatty acid studies with Tribolium would be relatively straight 
forward and should yield significant results, similar to those presented by Jeffries, 
et al. for melanogaster (12). RNAi and gene knockout studies in Tribolium are 
feasible, though time-consuming, very work-intensive and may not yield results 
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superior to a heavy-labeled feeding study thus far. A heavy-labeled feeding study 
with mellifera would be challenging, but may be possible using heavy-labeled 
glucose as a food supplement to isolated hives over a potentially significant period 
of time. Such experiments may yield similar results to a feeding study with 
Tribolium; however, the time frame needed may be difficult to achieve without 
saturating the organism with heavy-labeled carbon atoms yet also long enough to 
ensure adequate assimilation into the fatty acid biosynthetic route. A separate 
possibility would be to use heavy-labeled nitrogen supplemented into the honeybee 
and red flour beetle diets, making tracing the heavy-labeled molecules potentially 
easier because of the existence of a very distinct heavy atom. Proper 
RNAi/knockouts of mellifera is not currently feasible considering the nature, needs 
and behavior of the organism. 
A very clear next step in furthering this work would be the expression, 
purification and evaluation of a Tribolium or mellifera-based AANAT, similar to that 
done in Fruit flies by Dempsey, et al. (17, 35). Doing so can further confirm the 
biosynthesis of these compounds in insects using these enzymes. Additionally, the 
design, expression, purification and evaluation of any possible Tribolium/mellifera-
based Fatty Acid Amide Hydrolase (FAAH) enzyme should also be undertaken to 
begin elucidation of the degradation pathways in insects.  
Furthermore, both AANAT-knockout and FAAH-knockout Tribolium are 
feasible and may yield superior results to heavy-labeled feeding studies and RNAi 
experiments alone, by showing increases and decreases in endogenous levels while 
further specifying the nature and mechanism of the biosynthesis and degradation of 
eCBS/FAAs in these organisms. 
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Lastly, the need to determine the receptor(s) paired to these compounds in 
insects is a vital step in the overall progress of this research field, and may be the 
most challenging to date. The receptor-ligand pairing in both organisms is key to 
potentially utilizing the eCBs/FAAs in controlling or protecting Tribolium and 
mellifera species, respectively.  
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  Figure A.1. Standard Curves and Standard MS results for  
N-arachidonylethanolamine, AEA (anandamide)  
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 Figure A.2. Standard Curves and Standard MS results for the  
N-acylethanolamine OEA (oleoylethanolamine) 
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  Figure A.3. Standard Curve and Standard MS Results for the N-acyldopamine  
NPD. Note the presence of the quinone oxidation product in NPD at ~5.8 mins. 
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  Figure A.4. Standard Curve and Standard MS Results for the N-acyldopamine 
NOD. Note the presence of the “shadow” or overlapping peaks between 
NOD/NAD at ~5.9 mins. 
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Figure A.5. Standard Curve and Standard MS Results for the N-acyldopamine 
NOD. Note the presence of the “shadow” or overlapping peaks between 
NOD/NAD at ~5.9 mins. 
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Figure A.6. Standard Curve and Standard MS Results for N-palmitoylglycine, 
NPG. Note the distinct absence of compound overlap and oxidation products and 
the superior linearity as compared to the N-acyldopamine series. 
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Figure A.7. Standard Curve and Standard MS Results for N-oleoylglycine, NOG. 
Note the distinct absence of compound overlap and oxidation products and the 
superior linearity as compared to the N-acyldopamine series. 
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Figure A.8. Standard Curve and Standard MS Results for N-arachidonylglycine 
NAG. Note the distinct absence of compound overlap and oxidation products and 
the superior linearity as compared to the N-acyldopamine series. 
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 Figure A.9. Standard Curve and MS Results for N-oleoylserotonin, NOS. Note the 
clearly defined oxidation and/or overlapping “shadow” peaks with NOD and NAD 
at ~5.9 and ~6.2 minutes, respectively.  
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 Figure A.10. Standard MS Results of primary fatty acid amides linoleamide LOA 
  and palmitoleamide POA 
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 Figure A.11. Standard MS Results of primary fatty acid amides oleamide OA and 
palmitamide PA 
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Figure A.15. Aggregate spectra and MS results of endogenous AEA in farmed 
Figure A.15. Aggregate spectra and MS results of N-oleoyldopamine, NOD, in 
farmed A. mellifera. 
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Figure A.16. Aggregate spectra and MS of N-acylglycines NPG and NOG in 
farmed A. Mellifera 
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Figure A.17. Aggregate spectra and MS of N-acyl ethanolamines OEA and AEA 
in feral A. Mellifera 
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Figure A.18. Aggregate spectra and MS of N-acyldopamines NPD and 
NOD in feral A. Mellifera. NAD is a false positive of AEA. 
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Figure A.19. Aggregate spectra and MS of N-acylglycines, NPG, NOG and NAG, in 
feral A. mellifera. 
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 Figure A.20. Aggregate spectra and MS of endogenous primary fatty acid amides   
 LOA and POA in feral A. mellifera. 
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 Figure A.21. Aggregate spectra and MS of endogenous primary fatty acid amides   
 OA and PA in feral A. mellifera. 
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Figure A.22. Aggregate spectra and MS of endogenous ethanolamine AEA in T. 
castaneum. 
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Figure A.23. Aggregate spectra and MS of endogenous acyl dopamines, NPD, NOD, 
and NAD, in T. castaneum. 
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Figure A.24. Aggregate spectra and MS of endogenous acyl glycines, NPG, NOG and 
NAG, in T. castaneum. 
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Figure A.25. Aggregate spectra and MS of endogenous primary fatty acid amides, 
POA, OA and PA, in T. castaneum. 
